Anzeige
Mehr »
Login
Samstag, 23.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Microsofts, Googles und Amazons nukleares Wettrennen macht diese Uranaktie zu einem Muss!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1J6DY | ISIN: CA0906901081 | Ticker-Symbol:
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
BIOSYENT INC Chart 1 Jahr
5-Tage-Chart
BIOSYENT INC 5-Tage-Chart

Aktuelle News zur BIOSYENT Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoBioSyent Inc: BioSyent to pay 4.5-cent dividend Dec. 162
MiBioSyent declares CAD 0.045 dividend1
MiBioSyent Inc.: BioSyent Releases Financial Results for Q3 and YTD 202447MISSISSAUGA, Ontario, Nov. 20, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. ("BioSyent", TSX Venture: RX) released today its financial results for the three months (Q3) and nine months (YTD) ended September...
► Artikel lesen
MiBioSyent Inc.: BioSyent Declares Fourth Quarter 2024 Dividend2
13.11.BioSyent Inc: BioSyent to release Q3 results Nov. 201
13.11.BioSyent Inc.: BioSyent Schedules Q3 and YTD 2024 Earnings Release for November 20, 20243
04.11.BioSyent (CVE:RX) Sets New 1-Year High - Should You Buy?1
23.09.Insider Selling: BioSyent Inc. (CVE:RX) Director Sells 2,320 Shares of Stock2
BIOSYENT Aktie jetzt für 0€ handeln
20.09.BioSyent Inc: BioSyent acquires Tibelia assets for 2.8 M euros3
20.09.BioSyent Inc.: BioSyent Announces Agreement to Purchase Tibelia® (tibolone) Assets1
26.08.BioSyent Inc: BioSyent earns $1.58-million in Q2 20241
26.08.BioSyent Inc: BioSyent to pay 4.5-cent dividend Sept. 151
26.08.BioSyent declares CAD 0.045 dividend1
26.08.BioSyent Inc.: BioSyent Releases Financial Results for Q2 and H1 202484MISSISSAUGA, Ontario, Aug. 26, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. ("BioSyent", TSX Venture: RX) released today its financial results for the three months (Q2) and six months (H1) ended June 30...
► Artikel lesen
26.08.BioSyent Inc.: BioSyent Declares Third Quarter 2024 Dividend1
25.07.BioSyent Inc: BioSyent shareholder FAX sells 500,000 shares1
12.06.BioSyent Inc.: BioSyent In-Licenses Endocrinology Product for Canada1
17.05.BioSyent Inc.: BioSyent Releases Financial Results for Q1 2024318MISSISSAUGA, Ontario, May 16, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. ("BioSyent", TSX Venture: RX) released today its financial results for the three months (Q1) ended March 31, 2024. Key highlights...
► Artikel lesen
15.04.BioSyent Inc.: BioSyent Announces Extension of RepaGyn and Proktis-M Agreement153MISSISSAUGA, Ontario, April 15, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. ("BioSyent", "the Company", TSX Venture: RX) is pleased to announce that its wholly-owned subsidiary, BioSyent Pharma Inc. ("BioSyent...
► Artikel lesen
13.03.BioSyent Inc.: BioSyent Releases Financial Results for Fourth Quarter and Full Year 2023229MISSISSAUGA, Ontario, March 13, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. ("BioSyent", TSX Venture: RX) released today its financial results for the fourth quarter (Q4) and full year (FY) ended December...
► Artikel lesen
20 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1